Cargando…

10. Cardiovascular Risk in Chronic Kidney Disease

Detalles Bibliográficos
Autor principal:	Lainščak, Mitja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975273/ https://www.ncbi.nlm.nih.gov/pubmed/27683330

Ejemplares similares

Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges
por: Lainscak, Mitja, et al.
Publicado: (2015)

Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease
por: Roblek, Tina, et al.
Publicado: (2014)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
por: Clini, Enrico M., et al.
Publicado: (2014)

Cardiovascular Function in Intensive Care Medicine or Homo Mensura Est
por: Lainscak, Mitja, et al.
Publicado: (2016)

Living with Chronic Heart Failure: Exploring Patient, Informal Caregiver, and Healthcare Professional Perceptions
por: Sedlar, Natasa, et al.
Publicado: (2020)

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease
por: Pitt, Bertram, et al.
Publicado: (2018)

Hemodynamic Response to High- and Low-Load Resistance Exercise in Patients with Coronary Artery Disease: A Randomized, Crossover Clinical Trial
por: Kambic, Tim, et al.
Publicado: (2021)

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease
por: Lainscak, Mitja, et al.
Publicado: (2011)

Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke - a retrospective analysis
por: Haeusler, Karl Georg, et al.
Publicado: (2015)

ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker
por: Lainscak, Mitja, et al.
Publicado: (2016)

Embracing secondary mitral regurgitation with Carillon: past, present, and future
por: Lainscak, Mitja, et al.
Publicado: (2020)

Reproducibility of isokinetic knee testing using the novel isokinetic SMM iMoment dynamometer
por: Kambič, Tim, et al.
Publicado: (2020)

Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Objectively Measured Physical Activity in Patients with Coronary Artery Disease: A Cross-Validation Study
por: Kambic, Tim, et al.
Publicado: (2021)

Self‐care perception and behaviour in patients with heart failure: A qualitative and quantitative study
por: Sedlar, Natasa, et al.
Publicado: (2021)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

High-Load and Low-Load Resistance Exercise in Patients with Coronary Artery Disease: Feasibility and Safety of a Randomized Controlled Clinical Trial
por: Kambic, Tim, et al.
Publicado: (2022)

Cardiovascular risks in chronic kidney disease pediatric patients
por: Tian, Jing, et al.
Publicado: (2017)

Treating chronic kidney disease to reduce cardiovascular risk
por: Cice, Gennaro, et al.
Publicado: (2023)

Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease
por: Strandhave, Charlotte, et al.
Publicado: (2013)

Effects of high-load and low-load resistance training in patients with coronary artery disease: rationale and design of a randomised controlled clinical trial
por: Kambic, Tim, et al.
Publicado: (2021)

Optimisation of Heart Failure Management in Nursing Homes Using Point-of-Care Ultrasonography: Harmonious Trial Rationale and Design
por: Homar, Vesna, et al.
Publicado: (2020)

Combined resistance training with aerobic training improves physical performance in patients with coronary artery disease: A secondary analysis of a randomized controlled clinical trial
por: Kambic, Tim, et al.
Publicado: (2022)

Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk
por: Dourado, Marclébio, et al.
Publicado: (2020)

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
por: Omersa, Daniel, et al.
Publicado: (2016)

Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
por: Borg, Rikke, et al.
Publicado: (2023)

Chronic Kidney Disease And Associated Risk Factors Among Cardiovascular Patients
por: Chala, Getahun, et al.
Publicado: (2019)

Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk
por: Chia, Yook Chin, et al.
Publicado: (2015)

Cancer cachexia: an orphan with a future
por: Lainscak, Mitja, et al.
Publicado: (2019)

Response: Commentary: Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
por: Kambic, Tim, et al.
Publicado: (2021)

Comment on: “Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial” by Otsuka et al.
por: Kambič, Tim, et al.
Publicado: (2022)

Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: a randomised, controlled trial
por: Kambic, Tim, et al.
Publicado: (2023)

Regional differences in heart failure hospitalizations, mortality, and readmissions in Slovenia 2004–2012
por: Omersa, Daniel, et al.
Publicado: (2019)

Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors
por: Price, Anna M., et al.
Publicado: (2018)

Bacterial metabolites and cardiovascular risk in children with chronic kidney disease
por: Schlender, Julia, et al.
Publicado: (2021)

Knowledge and skills required to perform point-of-care ultrasonography in family practice – a modified Delphi study among family physicians in Slovenia
por: Homar, Vesna, et al.
Publicado: (2020)

Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous System
por: Park, Jeanie
Publicado: (2012)

Cardiovascular Risk Factors and Chronic Kidney Disease—FGF23: A Key Molecule in the Cardiovascular Disease
por: Jimbo, Rika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qem7rik8a6oj9nnjm56ruuq6u8